HIV/AIDS Drugs Sold Despite Known Dangerous Side Effects

Gilead Withheld Safer Medication

Lawsuits filed on behalf of more than 20,000 patients allege that there is mounting evidence that Gilead Science, the manufacturer of HIV medications using a drug compound known as tenofovir disoproxil fumarate (TDF), withheld a much safer drug compound, tenofovir alafenamide fumarate (TAF), from the market, choosing to place profits over people and produce the much more dangerous compound.  As a result, tens of thousands of patients across the country developed serious injuries, including:

1. • Chronic kidney disease (CKD) or declining kidney function
     
   • Acute kidney injury (AKI) or acute renal failure (ARF)
   • Avascular necrosis (AVN)
   • Jawbone and tooth loss

TDF Lawsuits Underway for Injured Patients

These lawsuits further allege that Gilead Science knowingly injured its patients by intentionally delaying the market introduction of TAF, the drug compound with a significantly better safety profile than TDF, the compound that Gilead chose to market. The lawsuits claim that the motive behind the delay was to maximize profits from TDF drug sales (in the neighborhood of $11 billion annually) before patents on these drugs expired.

Urgent Action Required

Putting profits before the wellbeing of patients is immoral as well as illegal. If you have been diagnosed with bone loss or kidney damage after taking Viread, Truvada, Atripla, Complera, or Stribild, contact The Joel Bieber Firm as soon as possible about your rights under the law. Consultations are always free of charge and may lead to your being compensated by Gilead Science for related medical and other expenses. Family members of patients who may have died as a result of these complications also may be eligible for compensation. Don’t delay. Call us now for free legal advice and for more information.